2024 annual financial data
Madrigal Pharmaceuticals 2024 Operating margin
Madrigal Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was -276.39%.
Operating income was -497,875,000 USD and net income was -465,892,000 USD.
Operating cash flow was -455,572,000 USD.
Get free Madrigal Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 180,133,000 USD
- Operating income
- -497,875,000 USD
- Net income
- -465,892,000 USD
- Operating cash flow
- -455,572,000 USD